canakinumab

The drug is prescribed for the treatment of periodic fever syndromes (CAP syndrome, TRAP syndrome, HID syndrome/MKD, familial Mediterranean fever), Still's disease (in adults and children), and for the symptomatic treatment of gouty arthritis attacks in adults.

Form: powder for injection solution

ATC: L04AC08

Manufacturer: Novartis Pharma Stein AG (manufacturing, quality control, primary and secondary packaging, batch release)

The drug is prescribed for the treatment of periodic fever syndromes (CAP syndrome, TRAP syndrome, HID syndrome/MKD, familial Mediterranean fever), Still's disease (in adults and children), and for the symptomatic treatment of frequent attacks of gouty arthritis in adults.

Form: solution for injection

ATC: L04AC08

Manufacturer: Novartis Pharma Stein AG (manufacturing, quality control (excluding bioanalysis), primary packaging, secondary packaging)